Skip to content

Clinical trials

Hyperlipidemias trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Country / region: France Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20055
20061
20081
20091
20139
20161
20171
20211
20221
20233
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated3
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen8
Pfizer6
Novartis Pharmaceuticals5
AstraZeneca2
89bio, Inc.1
French National Agency for Research on AIDS and Viral Hepatitis1
Ionis Pharmaceuticals, Inc.1
Solvay Pharmaceuticals1
Takeda1
University Hospital, Montpellier1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias27
Hypercholesterolemia11
Dyslipidemias7
Cardiovascular Diseases5
Myocardial Infarction4
Diabetes Mellitus3
Hyperlipoproteinemia Type II3
Stroke3
Atherosclerosis2
HIV Infections2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.